Learn about clinical trials and research opportunities in Diagnosis/Treatment section
Learn about clinical trials and research opportunities in Diagnosis/Treatment section
On this page:
Before searching for ocular melanoma clinical trials in any database, please be advised by the National Cancer Institute that "there are many lists of cancer clinical trials taking place in the United States. [...] Because of the many types of sponsors, no single list [database] contains every clinical trial."
Learn about these different types of clinical trial databases — maintained by the U.S. government, cancer centers, drug and biotech companies, and clinical trial listing/matching services — in NCI's "Steps to Find a Clinical Trial."
"ClinicalTrials.gov, a [free] resource provided by the U.S. National Library of Medicine, is a registry and results information database of clinical research studies sponsored or funded by a broad range of public and private organizations around the world."
"Information is provided by study sponsors and investigators, and they are responsible for ensuring that the studies follow all applicable laws and regulations."
Filling Out the Search Fields/Filters and Understanding Results:
Using the "Condition/Disease" Field When Searching ClinicalTrials.gov:
Note: The database automatically includes results for its predetermined synonyms (synonyms are listed in the results' "search details" tab).
1) To get started, look at search results using Ocular Melanoma to broadly describe the tumor. Then:
a) If the tumor is in the uvea, use Uveal Melanoma (which will also automatically search for synonym "intraocular melanoma" at the same time), and then try a separate search with the specific part of the uvea — Choroidal Melanoma, Iris Melanoma, or Ciliary Body Melanoma.
b) If the tumor is in the conjunctiva, use Conjunctival Melanoma.
Phone, Online Chat, and Email Support During Search:
"NCI's Cancer Information Service provides accurate, up-to-date, and reliable information that is easy to understand and free of charge. Our trained information specialists provide personalized responses to a range of cancer questions, including tailored clinical trials searches." [Note: ClinicalTrials.gov includes in its database all of the NCI-supported clinical trials, which are those sponsored or otherwise financially supported by the National Cancer Institute.]
1-800-422-6237 [toll free], Monday through Friday 9 a.m. – 9 p.m. Eastern Standard Time. Both phone support and one-on-one online chats are available during these hours. This service is also available in Spanish.
From National Cancer Institute
Topics include "What Are Clinical Trials?," "Paying for Clinical Trials," "Patient Safety," and "Questions to Ask Your Doctor about Clinical Trials." Be sure to click on the "+" sign next to each topic in the left-hand column of the guide to view subtopics.
(Also available in Spanish.)
From American Cancer Society
ACS provides a printable list of "Questions to Ask Before Joining a Clinical Trial" and discusses "Risks vs. Benefits" and "Common Concerns About Clinical Trials."
From TriageCancer.org
This section of Triage Cancer's website provides information on clinical trials coverage by private insurance, Medicaid, Medicare, Tricare, or VA. For details, click on "How to Pay for a Clinical Trial" in the green tabs at bottom of linked page.
From U.S. Department of Health and Human Services' Office for Human Research Protections
Resources include "Questions to Ask About Volunteering for a Research Study," "Regulations to Protect Research Volunteers," and "Short Videos About Participating in Human Research."
(Also available in Spanish.)
"Sometimes called 'compassionate use,' expanded access is a potential pathway for a patient with a serious or life-threatening disease or condition to try an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when there are no comparable or satisfactory therapies available. [...] There are times when it is not possible for a patient to be a part of a clinical trial. In those circumstances, expanded access may be the only way for a patient to receive an investigational medical product. The U.S. Food and Drug Administration is committed to increasing awareness about the expanded access process."
On the Advanced Search page of ClinicalTrials.gov:
New information added to this webpage: March 16, 2023
Links to all external sites re-verified on this webpage: March 24, 2023
Email: Erica@EyeMelanoma.org
This not-for-profit website does not contain any advertisements and does not receive funding/donations of any kind.
Information on this site should not be used as a substitute for professional medical care or advice.
Copyright © 2011–2023. EYEMELANOMA.ORG. All Rights Reserved.
EyeMelanoma.org has been providing current information on ocular melanoma since 2011.
This nonprofit website does not contain any advertisements and does not receive funding/donations of any kind.
Google Analytics is used within this site to determine the number of visitors. Data is anonymous.